Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Pharmacogenet Genomics. 2010 Nov;20(11):665–676. doi: 10.1097/FPC.0b013e32833f2cd0

Table 4.

Association analysis between non-responders and responders to MTX, across the SLC16A7 gene, in UK and US dataset.

SNP Gene CHR Position Minor allele Major allele UK MAF NR (n=51) UK MAF ACR-Ped70 (n=72) OR (95% CI) P trend US MAF NR (n=76) US MAF Joint count 70 (n=67) OR (95% CI) P trend
rs17122830 SLC16A7 12 58359507 G A 0.07 0.06 1.11 (0.40-3.07) 0.84 0.06 0.05 1.16 (0.42-3.2) 0.79
rs1497474 SLC16A7 12 58360056 T C 0.27 0.27 0.99 (0.56-1.77) 0.98 0.22 0.28 0.76 (0.44-1.29) 0.3
rs10877327 SLC16A7 12 58360452 T G 0.15 0.13 1.21 (0.58-2.52) 0.64 NT NT
rs7976956 SLC16A7 12 58365097 A G 0.25 0.23 1.12 (0.61-2.03) 0.73 NT NT
rs1000708 SLC16A7 12 58369755 G A 0.41 0.48 0.75 (0.44-1.29) 0.25 NT NT
rs7971953 SLC16A7 12 58376474 C G 0.20 0.26 0.70 (0.37-1.35) 0.28 0.25 0.28 0.87 (0.52-1.48) 0.62
rs12231740 SLC16A7 12 58390307 T C 0.38 0.28 1.61 (0.94-2.76) 0.07 0.28 0.20 1.56 (0.9-2.71) 0.12
rs2711669 SLC16A7 12 58415239 T C 0.09 0.07 1.45 (0.55-3.80) 0.43 0.07 0.04 1.5 (0.53-4.25) 0.46
rs2706301 SLC16A7 12 58421669 C G 0.38 0.44 0.79 (0.46-1.36) 0.36 NT NT
rs10877333 SLC16A7 12 58442313 G T 0.12 0.22 0.48 (0.23-0.98) 0.03 0.21 0.25 0.83 (0.48-1.45) 0.51
rs2711655 SLC16A7 12 58452688 G A 0.50 0.35 1.84 (1.10-3.09) 0.02 NT NT
rs12718000 SLC16A7 12 58455532 A G 0.09 0.09 0.91 (0.36-2.33) 0.84 NT NT
rs3763980 SLC16A7 12 58459623 A T 0.36 0.23 1.96 (1.11-3.44) 0.02 0.28 0.17 1.83 (1.01-3.31) 0.04
rs10784000 SLC16A7 12 58467231 G A 0.28 0.28 1.00 (0.57-1.75) 0.99 NT NT

NOTES : CHR=chromosome, MAF= minor allele, NR=non-responder; NT- not tested; significantly associated SNPs (p<0.05) in bold